Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Leonard Mermel, DO, ScM

Professor of Medicine
Warren Alpert Medical School of Brown University
Providence, RI, United States

Dr. Mermel is Professor of Medicine, Warren Alpert Medical School of Brown University, Adjunct Clinical Professor, University of Rhode Island College of Pharmacy and Medical Director of the Department of Epidemiology & Infection Control for the Lifespan Hospital System. He was 2005 President of the Society for Healthcare Epidemiology of America (SHEA), 2014 SHEA Mentor Scholar Award recipient, 2016 recipient of The Milton W. Hamolsky Outstanding Physician Award from the Rhode Island Hospital Medical Staff Association, 2021 SHEA Senior Scholarship Award recipient and 2021 Rhode Island ACP Milton Hamolsky Lifetime Achievement Award recipient. He was past recipient of the Ralph A. Kinsella, Sr. Memorial Tribute Award from St. Louis University Hospitals, SHEA Young Investigator Award, Brown Medical School Department of Medicine Chairman’s Award for Outstanding Teaching, Brown Medical School Dean’s Excellence in Teaching Award, and the Brown Medical School Certificate of Recognition for Exemplary Teaching. He is an elected member of Delta Omega, the Honorary Public Health Society. On his June 15, 2016 birthday, a Resolution was passed by the Rhode Island House of Representatives observing that day as ‘Dr. Leonard Alan Mermel Day’ in Rhode Island. Dr. Mermel has co-authored US guidelines on prevention and management of intravascular catheter infections, and co-authored over 400 articles, textbook chapters, and abstracts. Dr. Mermel and Dr. David Classen developed the idea for the Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals, now a standard guidance and the basis for various National Patient Safety Goals. His research focus has been the prevention of healthcare-associated infections.

Disclosure(s): Citius Pharma: Board Member (Ongoing), Honoraria (Ongoing); Pristine Access Technologies: Advisor/Consultant (Terminated, May 15, 2023)

Presentation(s):